TPSF
LGND icon

Texas Permanent School Fund’s Ligand Pharmaceuticals LGND Stock Holding History

Texas Permanent School Fund’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,344
Closed -$1.05M – 772
2024
Q1 		$1.05M Buy
14,344
+185
+1% +$13.6K 0.01% 1303
2023
Q4 		$1.01M Buy
14,159
+304
+2% +$17.9K 0.01% 1303
2023
Q3 		$830K Sell
13,855
-593
-4% -$39K 0.01% 1309
2023
Q2 		$1.04M Buy
14,448
+55
+0.4% +$4.13K 0.01% 1247
2023
Q1 		$1.06M Buy
14,393
+3,603
+33% +$256K 0.01% 1222
2022
Q4 		$721K Sell
10,790
-7,707
-42% -$501K 0.01% 1241
2022
Q3 		$994K Sell
18,497
-1,039
-5% -$61.1K 0.02% 1101
2022
Q2 		$1.09M Buy
19,536
+544
+3% +$30.9K 0.02% 1082
2022
Q1 		$1.33M Sell
18,992
-324
-2% -$23.5K 0.02% 1053
2021
Q4 		$1.86M Sell
19,316
-460
-2% -$42.5K 0.02% 945
2021
Q3 		$1.72M Sell
19,776
-116
-0.6% -$8.97K 0.02% 977
2021
Q2 		$1.63M Sell
19,892
-3
-0% -$250 0.02% 1040
2021
Q1 		$1.89M Sell
19,895
-803
-4% -$75.9K 0.02% 939
2020
Q4 		$1.28M Sell
20,698
-3,373
-14% -$192K 0.02% 1059
2020
Q3 		$1.43M Buy
24,071
+3,743
+18% +$255K 0.02% 959
2020
Q2 		$1.42M Sell
20,328
-2,069
-9% -$131K 0.02% 866
2020
Q1 		$1.02M Buy
22,397
+3,140
+16% +$178K 0.02% 951
2019
Q4 		$1.25M Sell
19,257
-1,486
-7% -$99.3K 0.02% 996
2019
Q3 		$1.29M Sell
20,743
-579
-3% -$36.4K 0.02% 949
2019
Q2 		$1.52M Sell
21,322
-931
-4% -$68.6K 0.02% 872
2019
Q1 		$1.75M Sell
22,253
-42
-0.2% -$3.18K 0.03% 781
2018
Q4 		$1.89M Buy
22,295
+1,009
+5% +$108K 0.03% 676
2018
Q3 		$3.65M Sell
21,286
-771
-3% -$116K 0.05% 410
2018
Q2 		$2.85M Sell
22,057
-339
-2% -$37.8K 0.04% 563
2018
Q1 		$2.31M Sell
22,396
-472
-2% -$46.7K 0.03% 684
2017
Q4 		$1.95M Sell
22,868
-1,615
-7% -$140K 0.02% 803
2017
Q3 		$2.08M Buy
24,483
+2,203
+10% +$174K 0.03% 783
2017
Q2 		$1.69M Buy
22,280
+255
+1% +$17.8K 0.02% 871
2017
Q1 		$1.45M Sell
22,025
-212
-1% -$13.9K 0.02% 938
2016
Q4 		$1.41M Sell
22,237
-938
-4% -$59.2K 0.02% 952
2016
Q3 		$1.48M Sell
23,175
-49
-0.2% -$3.6K 0.02% 915
2016
Q2 		$1.73M Sell
23,224
-28
-0.1% -$2.08K 0.02% 810
2016
Q1 		$1.55M Sell
23,252
-825
-3% -$50.1K 0.02% 888
2015
Q4 		$1.63M Buy
24,077
+135
+0.6% +$8.34K 0.02% 868
2015
Q3 		$1.28M Sell
23,942
-464
-2% -$28.2K 0.02% 991
2015
Q2 		$1.54M Sell
24,406
-1,316
-5% -$71.8K 0.02% 958
2015
Q1 		$1.24M Sell
25,722
-574
-2% -$22K 0.01% 1091
2014
Q4 		$873K Sell
26,296
-1,194
-4% -$38.8K 0.01% 1214
2014
Q3 		$806K Sell
27,490
-6,096
-18% -$202K 0.01% 1215
2014
Q2 		$1.3M Buy
33,586
+231
+0.7% +$9.37K 0.01% 1109
2014
Q1 		$1.4M Sell
33,355
-1,068
-3% -$44.5K 0.01% 1065
2013
Q4 		$1.13M Buy
+34,423
New +$1.12M 0.01% 1170

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Texas Permanent School Fund's LGND Position: Q2 2024 in Review

Texas Permanent School Fund sold out of Ligand Pharmaceuticals (LGND) in Q2 2024, closing a stake of 14,344 shares — an estimated $1.05M sold.

Texas Permanent School Fund first reported a position in LGND in Q4 2013 and held it in 42 quarters. The position peaked at $3.65M in Q3 2018. 234 funds tracked by Wall St. Rank hold LGND as of Q2 2024.

  • Texas Permanent School Fund reported no remaining Ligand Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Texas Permanent School Fund sold 14,344 Ligand Pharmaceuticals shares in Q2 2024, an estimated $1.05M.
  • Texas Permanent School Fund first reported a position in Ligand Pharmaceuticals in Q4 2013 and held it in 42 quarters.
  • Texas Permanent School Fund's Ligand Pharmaceuticals position peaked at $3.65M in Q3 2018.
  • 234 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2024.

Based on Texas Permanent School Fund's 13F filing for Q2 2024, filed 7 Aug 2024.